There were no significant differences in the proportions of CD103+CD3+ T cells, CD103+CD4+ T cells, and CD103+CD8+ T cells between patients with DN-AML and those with DN-B-ALL (Figure 1B). This evidence concerns the gene ITGAE and acute myeloid leukemia.